Clinical Trial At Hackensack University Medical Center Aims To Offer Treatment For Alzheimer's Agitation

Mahwah NJ

16 September, 2021

9:36 AM

Description

CBS New York September 16, 2021 One of the biggest stress inducers for Alzheimer's disease caregivers is not memory loss but agitation. It can take on many forms and afflicts 80-90% of Alzheimer's patients. CBS2's Dr. Max Gomez says there are no FDA-approved drugs for Alzheimer's agitation, but there is a new clinical trial just beginning that could change that. CBS Local Digital Media personalizes the global reach of CBS-owned and operated television and radio stations with a local perspective.